Transgene Announces Upcoming Investor Meetings

On September 13, 2021 Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapeutics against cancer, reported that Management will participate in the upcoming investor events set out below (Press release, Transgene, SEP 13, 2021, View Source [SID1234587622]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

– Investor Access Forum – Physical event (Paris, France)
September 27 & 28, 2021

– HealthTech Innovation Days 2021 – Digital & physical event (Paris, France)
October 4 & 5, 2021

-European Midcap Event – Digital & physical event (Paris, France)

October 21 & 22, 2021

– EigenKapitalForum – Digital event

November 22, 2021

-Investir Day – Physical event (Paris, France)

November 23, 2021